bioRxiv · 10.1101/2024.08.06.606795
Microglia determine beta-amyloid plaque burden but are non-essential for downstream pathology
Abstract
Evidence points to a role for microglia in Alzheimers disease (AD) risk, although their position in the pathological cascade is incompletely understood, prompting us to generate a model of {beta}-amyloidopathy lacking microglia. We find evidence that microglia promote plaque formation and creation of an A{beta} fibril-rich zone surrounding the plaque core. However, plaque-proximal reactive astrogliosis, synapse loss, and neurite dystrophy are still observed in the absence of microglia.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Li, M., Holt, K., Ridley, K., Qiu, J., Haddow, K., Vasoya, D., He, X., Tulloch, J., King, D., Hume, D. A., Pridans, C., Dando, O. R., Spires-Jones, T. L., Hardingham, G. E.. 2024-08-08. Microglia determine beta-amyloid plaque burden but are non-essential for downstream pathology. https://doi.org/10.1101/2024.08.06.606795
Cite the original work for its findings. Save a collection to share your selection of sources.